<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:department>Institute of Human Genetics</gtr:department><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/83AAD002-A9D0-4F8C-88B9-C3DB138920E0"><gtr:id>83AAD002-A9D0-4F8C-88B9-C3DB138920E0</gtr:id><gtr:firstName>Roslyn</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Simms</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802359"><gtr:id>EB647353-659D-414A-B8AF-B16DED77ABE2</gtr:id><gtr:title>Cellular and genetic models of inherited cystic kidney disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0802359</gtr:grantReference><gtr:abstractText>Cystic kidney disease comprises a group of inherited disorders leading to kidney failure. Cystic kidney disease accounts for 10% of the 40,000 UK patients requiring renal replacement therapy (dialysis and transplantation). Current treatment of cystic kidney disease is supportive rather than preventing disease progression. A better understanding of the disease processes involved is required and experimental models will enable new drugs to be tested.
Recently some of the genes mutated in the childhood cystic kidney disease called nephronophthisis have been found. The genes code for proteins called nephrocystins, which have important roles in how the kidney tubules form and orientate themselves. Before cysts develop, patients are unable to concentrate their urine, providing a useful hint that affected kidney cells cannot function at a molecular level. We will investigate, using kidney cells in culture and developing zebrafish where these proteins are located and how they interact to control water reabsorption. In these model systems we will mimic the human disease of nephronophthisis, to determine the underlying processes which lead to cyst formation and evaluate certain drugs which may be important is slowing down this disease.</gtr:abstractText><gtr:technicalSummary>Nephronophthisis (NPHP), an autosomal recessive cystic kidney disease, is the most common genetic cause of renal failure in children and young adults. The disease progresses rapidly and treatment, by dialysis or renal transplantation, is merely supportive. 

Molecular genetics have recently identified a number of NPHP genes, yet the function of nephrocystin proteins remains obscure. The phenotype of NPHP includes a marked concentration defect prior to the development of renal failure, suggesting specific tubular defects underlie the pathogenesis of this condition, which may be amenable to treatment. 
Aims and objectives

1. We will determine the physiological role of nephrocystin proteins and the effect of nephrocystin gene silencing in a renal collecting duct cell model system.

2. Using zebrafish models of nephronophthisis, we will determine the genetic interactions of nephrocystins in terms of kidney development and renal function. 

3. Using renal cell models and zebrafish developmental models of NPHP, we will determine the effect of therapeutic agents in these experimental models.

Design and methodology

A functional model of the renal collecting duct (murine CCDcl4 cells) will be utilised, where there is endogenous expression of aquaporin-2 and nephrocystin proteins. The physiological effects of AVP and forskolin upon nephrocystin protein expression will be quantified using Western blotting and immunocytochemistry following stimulation. NPHP gene upregulation will be assessed by quantitative RT-PCR in control and treated cells. The effect of NPHP gene silencing (using siRNA directed towards NPHP1, AHI1 and NPHP6) will be assessed. Specifically, changes in cAMP, aquaporin-2, cell polarity, cilia formation and tight junction formation will be assessed using Western blotting, immunocytochemistry and confocal microscopy.

The zebrafish will be used as an embryological system to explore mechanisms of renal development in nephronophthisis, using gene specific antisense morpholino oligonucleotide (MO) injections. Single antisense MO and combinations of antisense MOs will be injected, directed towards NPHP6, AHI1 and NPHP1. Observation of zebrafish organogenesis will determine the genetic interactions of NPHP genes. Rhodamine-labelled dextran will be injected and used to estimate glomerular filtration rate (GFR), in order to determine kidney function in developing fish and to quantify the effects of nephrocystin gene knockdown in this model system.
Cell layers and zebrafish models of NPHP will be treated with therapeutic agents such as vasopressin antagonists, rapamycin and roscovitine to determine effects at a molecular and developmental level. Rescue of phenotypes will be determined in cell culture systems using confocal microscopy, and in zebrafish by using GFR measurements.</gtr:technicalSummary><gtr:fund><gtr:end>2011-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>171680</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leeds</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine and Health</gtr:department><gtr:description>MKS3 knockdown in Zebrafish models the ciliopathy Meckel Gruber Syndrome</gtr:description><gtr:id>E99C4D58-2443-4809-934E-864EEF94DB54</gtr:id><gtr:impact>MKS3 knockdown in zebrafish models the ciliopathy Meckel Gruber Syndrome - Poster presentation, American Society of Nephrology, Denver, November 2010
The following paper, &amp;quot;A meckelin-filamin A interaction mediates ciliogenesis&amp;quot; has been provisionally accepted by Human Molecular Genetics and is prending publication (November 2011).</gtr:impact><gtr:outcomeId>JeabYjUoc8a-1</gtr:outcomeId><gtr:partnerContribution>Cellular models and patient data, hopeful this collaboration with lead to a substantive publication.</gtr:partnerContribution><gtr:piContribution>I have performed all of the zebrafish experiments.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>ADPKD Rare Disease Working Group</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C6A519B9-265A-4DA1-9834-7CE3B7BDB48A</gtr:id><gtr:impact>I have recently joined this group, we communicate by email and I am attending my first meeting in January 2013. The aim is to develop a patient database, generate guidelines for investigations/management for patients with ADPKD and hopefully enable future clinical trials.

One of the UK Renal Associations rare disease working groups.</gtr:impact><gtr:outcomeId>jMs2hjKtkqS</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PKD Patient Information Day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>47B57136-8AB1-4242-B871-3170B17F555C</gtr:id><gtr:impact>Approximately 60 patients attended a Polycystic Kidney Disease Patient Information Day during which I gave a 45 minute lecture on Recent PKD trials and research updates.

My presentation prompted questions inlcuding on my own research and on acquisition of funding.</gtr:impact><gtr:outcomeId>RFebAqm6VFm</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kidney Research UK Alumni Committee</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9742CF39-955B-4818-9383-C542B061D83F</gtr:id><gtr:impact>Email contact sharing ideas to develop a Kidney Research UK Alumni which will support, educate and stimulate all researchers throughout their careers from initial award of a Kidney Research UK grant.

3 educational meetings annually have successfully been established and a web based interaction for researchers.</gtr:impact><gtr:outcomeId>L2ce3RHV9sj</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kidney Research UK Annual Review</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C64C4B61-03EA-4FAB-80D6-01315A59C220</gtr:id><gtr:impact>I presented some of my research data at Kidney Research UK (my co-funding body) Fellows Day in September 2010. I was awarded a prize for Best Oral Presentation and subsequently this work is going to be included in the Kidney Research UK Annual Review. This is a publication sent to donators/patients/general public and aims to include researchers who are currently believed to be doing some ground breaking work in the Renal field.

The publication is currently in press.</gtr:impact><gtr:outcomeId>ZK9xBhUjHEz</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ARPKD Working Group</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2985EEA5-76F7-421E-B2E6-6AA16F99F04D</gtr:id><gtr:impact>We communicate by email and meet ~4 times/year to develop a patient database and generate guidelines for patients with ARPKD.

A patient information day was held in June 2012 which many families reported considerably improved their awareness and provided them with supportive resources.</gtr:impact><gtr:outcomeId>ZFZrgbWodUo</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kidney Research UK Legacy Reception</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A9DCAD0C-42DE-407E-907C-A9DA0B91FC04</gtr:id><gtr:impact>15-20 potential benefactors attended a Legacy reception in which I was the invited speaker. I gave a presentation regarding my research and the impact of kidney disease this stimulated questions and discussion.

I was advised that the presentation had successfully led to funding and donations for the Kidney Research UK charity - who co-funded my research with the MRC.</gtr:impact><gtr:outcomeId>MszRgvNFjr6</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2012,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Teaching students on Zebrafish Course, Utrecht, Holland</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C9FD56B1-F3D4-480B-9243-50E24FD26B8A</gtr:id><gtr:impact>40 international students attending a zebrafish course in Utrecht, Holland along with Principle Investigators/course organisers attended my presentation which stimulated questions and discussion.

Our group has had on going communication and visits to our laboratory from the Principle Investigator who organised the meeting. A collaboration is possible for future work.</gtr:impact><gtr:outcomeId>PCXR2H1btyo</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kidney Research UK, House of Lords visit</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>37122362-71A8-4382-8189-033F11A055FA</gtr:id><gtr:impact>Invited to attend an event organised by Kidney Research UK at the House of Lords to promote release of the new Kidney Research national agenda. Raising awareness of the need for kidney research.</gtr:impact><gtr:outcomeId>56bd993f2d3553.03409930</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Academy of Medical Sciences Starter Grant for Clinical Lecturers</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Academy of Medical Sciences (AMS)</gtr:fundingOrg><gtr:id>361558A9-FA8E-455B-9426-E3BC5E3841BD</gtr:id><gtr:outcomeId>56bd92e41e8c99.59220463</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>8000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Northern Counties Kidney Research Grant</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Northern Counties Kidney Research Fund</gtr:fundingOrg><gtr:fundingRef>BH136723</gtr:fundingRef><gtr:id>3BD24775-590F-419A-B012-206FD271FF72</gtr:id><gtr:outcomeId>icrJtpT6gqT</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ARPKD Working Group</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>13BFAA87-AC28-4F97-B970-F72EC6A36DB6</gtr:id><gtr:outcomeId>DvyQWMmNvtq</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ADPKD Working Group</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9368B246-F92C-447E-BD5A-011A6A4CC2EC</gtr:id><gtr:outcomeId>inVZrZDf1xT</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Zebrafish embryos are microinjected with an antisense morpholino oligonucleotide to inhibit a target gene and evaluated for signs representative of human disorders. I have targeted the following genes to create novel zebrafish models of human disease:
AHI1 models nephronophthisis and Joubert Syndrome
MKS3 models Meckel Gruber Syndrome and Joubert Syndrome
MKS3 and Filamin A in Meckel Gruber Syndrome</gtr:description><gtr:id>7109F97B-ACCE-480F-92DF-C466E9C9A268</gtr:id><gtr:impact>Results of combined MKS3 and Filamin A zebrafish work suggests an interaction between these two ciliopathy genes. This work is part of a collaboration with the Ciliopathy Research Group in Leeds who are evaluating cellular physiology.</gtr:impact><gtr:outcomeId>LGHMDabYX7b</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Zebrafish models of Joubert Syndrome and Meckel Gruber Syndrome</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3FC0CA9E-8BEE-4D5B-8C05-CBDD061BF7B6</gtr:id><gtr:title>Investigating embryonic expression patterns and evolution of AHI1 and CEP290 genes, implicated in Joubert syndrome.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/936af102cad7caf85dffaf1abc5f1d28"><gtr:id>936af102cad7caf85dffaf1abc5f1d28</gtr:id><gtr:otherNames>Cheng YZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_16549_29_23028714</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BCEC15E-A26A-4E55-A44E-24BC41085590</gtr:id><gtr:title>A meckelin-filamin A interaction mediates ciliogenesis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e4fad0283a1421bafc0b2b1e0e44b16"><gtr:id>4e4fad0283a1421bafc0b2b1e0e44b16</gtr:id><gtr:otherNames>Adams M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>kbNR2yz39B7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A1F2627-F6A2-4F00-BF5A-4047179A8807</gtr:id><gtr:title>Modelling a ciliopathy: Ahi1 knockdown in model systems reveals an essential role in brain, retinal, and renal development.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbce15e45cda9a6983c8d82dba6464a8"><gtr:id>dbce15e45cda9a6983c8d82dba6464a8</gtr:id><gtr:otherNames>Simms RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>FVNA69Ctheg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FEAB8BA-F82F-48FE-8A40-7845D83C0CAB</gtr:id><gtr:title>Nephronophthisis.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbce15e45cda9a6983c8d82dba6464a8"><gtr:id>dbce15e45cda9a6983c8d82dba6464a8</gtr:id><gtr:otherNames>Simms RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>fx5LU4uCRuj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE668124-0693-47BA-A350-56E3DACD0D74</gtr:id><gtr:title>Juvenile nephronophthisis on MRI--a potential case of Joubert syndrome?</gtr:title><gtr:parentPublicationTitle>Pediatric radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbce15e45cda9a6983c8d82dba6464a8"><gtr:id>dbce15e45cda9a6983c8d82dba6464a8</gtr:id><gtr:otherNames>Simms RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0301-0449</gtr:issn><gtr:outcomeId>KLXPyiUETzC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEE356F7-4506-4BC4-9E04-A22CD270DF96</gtr:id><gtr:title>Posttransplant lymphoproliferative disorder presenting as multiple cystic lesions in a renal transplant recipient.</gtr:title><gtr:parentPublicationTitle>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfbbb8a5143294e7767391b0d93da112"><gtr:id>cfbbb8a5143294e7767391b0d93da112</gtr:id><gtr:otherNames>Moir JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1600-6135</gtr:issn><gtr:outcomeId>pm_16549_29_22244123</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E95FE42-2214-4ADD-B613-D7BF035EDB72</gtr:id><gtr:title>Nephronophthisis: a genetically diverse ciliopathy.</gtr:title><gtr:parentPublicationTitle>International journal of nephrology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbce15e45cda9a6983c8d82dba6464a8"><gtr:id>dbce15e45cda9a6983c8d82dba6464a8</gtr:id><gtr:otherNames>Simms RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>dQzXEdRFLzK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B76B3C92-1AFC-431D-B744-261E5626AC67</gtr:id><gtr:title>Oxford Textbook of Clinical Nephrology</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3659679815e0def140bf803bd6f47532"><gtr:id>3659679815e0def140bf803bd6f47532</gtr:id><gtr:otherNames>Sayer J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56bd8ebd775369.21134839</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74ECB429-A785-49F3-A3AE-6DB2595FC3F4</gtr:id><gtr:title>AHI1 KNOCKDOWN IN ZEBRAFISH MODELS THE CILIOPATHY JOUBERT SYNDROME</gtr:title><gtr:parentPublicationTitle>PEDIATRIC NEPHROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72624c72e919ed753444a7d0b489004b"><gtr:id>72624c72e919ed753444a7d0b489004b</gtr:id><gtr:otherNames>Simms R. J.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0931-041X</gtr:issn><gtr:outcomeId>q6hBw7tVMKd</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802359</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>2EEE0958-6BE1-4D16-B86B-5D954CD37219</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Renal and Urogenital</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>